Patents Examined by Robert L. Stoll
  • Patent number: 5312904
    Abstract: Tridentate mono-anionic ligands have the structureX-A-Y-Q-Zwhere each of X and Y is independently P, As or N,Z is phenol, thiophenol or thiol, andA and Q are hydrocarbon linking groups.The ligands from cationic complexes with Technetium-99m, e.g. [Tc.sup.III K.sub.2 ].sup.+ where K is the ligand, having useful imaging properties.
    Type: Grant
    Filed: May 4, 1992
    Date of Patent: May 17, 1994
    Assignee: Amersham International plc
    Inventors: James D. Kelly, Kwok W. Chiu, David V. Griffiths, Jonathan R. Dilworth
  • Patent number: 5312952
    Abstract: This invention relates to a vinyl aromatic. Compounds of Structure (I): ##STR1## wherein R is C.sub.9 -C.sub.20 alkyl, Y is NO.sub.2, SO.sub.3 R' or H, R' is C.sub.1 -C.sub.20 alkyl, X is NO.sub.2 or C1-C.sub.20 alkyl, and R" is H or C.sub.1 -C.sub.20 alkyl, m is 2 or 3 and n is 0,1,2,3, with the proviso that when R is C.sub.9 and n=O, X and Y may not both be NO.sub.2.
    Type: Grant
    Filed: April 23, 1992
    Date of Patent: May 17, 1994
    Assignee: Uniroyal Chemical Company, Inc.
    Inventors: Anthony V. Grossi, Paul E. Stott, John M. DeMassa, Howard S. Friedman, Gerald J. Abruscato
  • Patent number: 5312564
    Abstract: A novel optically active liquid crystal compound and a liquid crystal composition containing the same are provided, which compound is expressed by the formula ##STR1## wherein R.sub.1 is alkyl or alkoxy of 4-18 C; R.sub.2 is alkyl, alkoxy, acyl or alkoxymethyl of 4-18C; but either one of R.sub.1 or R.sub.2 is an optically active group; either one of X.sub.1 or X.sub.2 is halogen atom and the other is H; m and n each are 0 or 1 and m+n is 0 or 1.
    Type: Grant
    Filed: December 31, 1992
    Date of Patent: May 17, 1994
    Assignee: Chisso Corporation
    Inventors: Kazutoshi Miyazawa, Hiromichi Inoue, Shinichi Saito, Takashi Inukai, Kanetsugu Terashima, Mitsuyoshi Ichihashi
  • Patent number: 5310433
    Abstract: An efficient method for preparing nitrated glycerol glycol ether useful as a high energy plasticizer, by using as nitrator feed, the reaction products of an alkali metal bisulfate-catalyzed reaction of ethylene oxide and a stoichiometric excess of glycerol.
    Type: Grant
    Filed: December 24, 1987
    Date of Patent: May 10, 1994
    Assignee: Hercules Incorporated
    Inventors: Lawrence E. Carosino, Kenneth O. Hartman
  • Patent number: 5310539
    Abstract: The present invention involves an image-enhancing agent comprising melanin combined with an essentially non-dissociable signal-inducing metal. The signal-inducing metal has an association constant for its melanin combination of at least about 10.sup.20. Upon suspension or dissolution in water the metal remains undissociated. A preferred signal-inducing metal is paramagnetic or superparamagnetic, of course for magnetic resonance imaging. A preferred paramagnetic or superparamagnetic metals are gadolinium, iron, nickel, copper, erbium, europium, praseodymium, dysprosium, holmium, chromium or manganese. Gadolinium is the most effective metal. The metal is incorporated into the melanin in an ionic or particulate form. Metals may be utilized which are particularly useful to modify ultrasound images by the enhancement of the image obtained from emission and detection of high-frequency soundwaves. Metals emitting gamma particles may also be utilized to enhance images resulting from gamma particle emission scanning.
    Type: Grant
    Filed: April 15, 1991
    Date of Patent: May 10, 1994
    Assignee: Board of Regents, The University of Texas System
    Inventor: Robert F. Williams
  • Patent number: 5310536
    Abstract: Amide-thiolate ligands having improved metal chelate formation kinetics are disclosed. The ligands include a tertiary amine strategically located to facilitate rapid formation of an amine-amide-thiolate intermediate complex, followed by transfer of the metal to a thermodynamically stable amide-thiolate complex. The amide-thiolate ligands of the present invention may be used for post formed labeling of biological substances for use in the fields of diagnosis and therapy.
    Type: Grant
    Filed: February 6, 1992
    Date of Patent: May 10, 1994
    Assignee: Mallinckrodt Medical, Inc.
    Inventor: Ananthachari Srinivasan
  • Patent number: 5310535
    Abstract: A group of functionalized polyaminocarboxamide modified chelators that form complexes with rare earth-type metal ions are disclosed. The complexes, covalently attached to an antibody or antibody fragment, can be used for therapeutic and/or diagnostic purposes.
    Type: Grant
    Filed: April 24, 1992
    Date of Patent: May 10, 1994
    Assignees: The Dow Chemical Company, The University of Texas
    Inventors: William J. Kruper, Jr., William A. Fordyce, A. Dean Sherry
  • Patent number: 5310500
    Abstract: Antiferroelectric liquid crystal compounds are provided which have the formula ##STR1## wherein R.sub.1 represents an alkyl group having 5-18 carbon atoms,R.sub.
    Type: Grant
    Filed: June 5, 1992
    Date of Patent: May 10, 1994
    Assignee: Showa Shell Sekiyu Kabushiki Kaisha
    Inventors: Yoshihiko Aihara, Tadaaki Isozaki, Toru Ooide, Noriko Yamakawa
  • Patent number: 5310912
    Abstract: An iodinated neuroprobe is provided for mapping monoamine reuptake sites. The iodinated neuroprobe is of the formula: ##STR1## wherein R=a C.sub.n H.sub.2n+1 group where n=0-6, an alkenyl group, a monofluoroalkyl group including .sup.n F where n=18 or 19, or a .sup.m C.sub.n H.sub.2n+1 group where n=1-6 and where m=11 or 14 for at least one .sup.m C;R'=a C.sub.n H.sub.2n+1 group where n=0-6, a p-iodophenylmethyl group, a p-iodophenylethyl group, a phenylmethyl group, or a phenylethyl group;X=an isotope of F, an isotope of Cl, an isotope of Br, an isotope of I, CH.sub.3, or Sn(R".sub.1 R".sub.2 R".sub.3);R".sub.1 =a C.sub.n H.sub.2n+1 group where n=1-6, or an aryl group;R".sub.2 =a C.sub.n H.sub.2n+1 group where n=1-6, or an aryl group;R".sub.3 =a C.sub.n H.sub.2n+1 group where n=1-6, or an aryl group; andY=H only if X is an isotope of I, or R' is a p-iodophenylmethyl group, or R' is a p-iodophenylethyl group, else Y=an isotope of I.Related analogs are also provided.
    Type: Grant
    Filed: February 25, 1992
    Date of Patent: May 10, 1994
    Assignee: Research Biochemicals Limited Partnership
    Inventors: John L. Neumeyer, Richard A. Milius, Robert B. Innis
  • Patent number: 5308603
    Abstract: The invention is a novel method and kit for directly radiolabeling proteins such as antibodies or antibody fragments for diagnostic and therapeutic purposes. The method comprises incubating a protein-containing solution with a solution of sodium ascorbate; adding a required quantity of reduced radionuclide to the incubated protein. A kit is also provided wherein the protein and/or reducing agents may be in lyophilized form.
    Type: Grant
    Filed: October 2, 1990
    Date of Patent: May 3, 1994
    Assignee: Thomas Jefferson University
    Inventor: Mathew L. Thakur
  • Patent number: 5308605
    Abstract: A method or the treatment and diagnosis of tumors is disclosed. This method comprises the administration of an effective amount of a radiohalogenated pyrimidine nucleoside to the tumor affected site.
    Type: Grant
    Filed: August 27, 1992
    Date of Patent: May 3, 1994
    Assignee: The President and Fellows of Harvard College
    Inventors: Amin I. Kassis, S. James Adelstein
  • Patent number: 5308604
    Abstract: The invention relates to conjugates composed ofa) at least one polyalcohol or a derivatized polyalcohol,b) at least one active agent,c) at least one linker andd) a protein,wherein the polyalcohol(s) or the derivatized polyalcohol(s) are polyalcohols or derivatized polyalcohols which are not recognized by the defense system of an organism as exogenous, and the protein is a protein which can be taken up by the tumor specifically or non-specifically, and is not recognized by the defense system of an organism as exogenous. These conjugates are suitable for, on the one hand, making possible a very sensitive method in nuclear medicine for the diagnosis of tumors and, on the other hand, for example also offering new methods for diagnosing tumors in X-ray diagnosis, computerized tomography, nuclear spin tomography, electron spin resonance spectroscopy or electron microscopy.
    Type: Grant
    Filed: March 26, 1992
    Date of Patent: May 3, 1994
    Assignee: Deutsches Krebsforschungsinstitut
    Inventors: Hansjorg Sinn, Hans-Hermann Schrenk, Wolfgang Maier-Borst, Eckhard Friedrich, Georgi Graschew, Dieter Worhle
  • Patent number: 5308533
    Abstract: A porous light-weight getter which collects particulate and molecular contaminates that is believed a significant improvement over the prior art is provided in which a metal mesh matrix is coated with a low-density porous aerogel. In the prior art bare metal mesh matrices have been employed as getters, which are subject to ablation from high-velocity contaminant particles. In the composite getter of the present invention, the low-density aerogel coating protects the enclosed metal matrix from ablation and also can attract and hold the incoming high-velocity particle. On its part, the metal mesh provides reinforcing support to the aerogel covering and also good thermal conductivity therein so that such covering can be cooled to the low temperatures that attract such contaminants. The invention further provides method for manufacture of the composite getters of the invention.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: May 3, 1994
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Steven P. Hotaling, Deidra A. Dykeman
  • Patent number: 5308535
    Abstract: The invention relates to electro-optical systems containing an addressable liquid-crystal layer and a device for compensating for the optical path difference d.multidot..DELTA.n of the addressable liquid-crystal layers, the compensating device being based on a liquid-crystalline polymer.
    Type: Grant
    Filed: August 27, 1990
    Date of Patent: May 3, 1994
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Bernhard Scheuble, Bernhard Rieger, Dieter Dorsch
  • Patent number: 5308540
    Abstract: Liquid crystalline compounds having an optionally active .gamma.-lactone ring of the formula: ##STR1## wherein R.sup.1 is a group selected from the group consisting of ##STR2## n and e are each independently 0 or 1; R.sup.3 is an alkyl group having 1 to 15 carbon atoms; R.sup.2 is a group of the formula: --(CO).sub.m --R.sup.4 ; m is 0 or 1; R.sup.4 is hydrogen atom or an alkyl having 1 to 15 carbon atoms; and the symbol * is an asymmetric carbon atom, and an intermediate thereof, and process for the production of the same.
    Type: Grant
    Filed: July 16, 1992
    Date of Patent: May 3, 1994
    Assignee: Daiso Co., Ltd.
    Inventors: Kazuhiko Sakaguchi, Naoya Kasai, Yoshikazu Takehira, Tohru Kitamura, Yutaka Shiomi
  • Patent number: 5308606
    Abstract: A method for therapeutic and/or diagnostic treatment of soft tumor carcinoma in mammals using certain metals or particle-emitting radionuclides complexed with hydroxyethylethylenediaminetriacetic acid is described.
    Type: Grant
    Filed: January 30, 1991
    Date of Patent: May 3, 1994
    Assignee: The Dow Chemical Company
    Inventors: David A. Wilson, R. Keith Frank, Joseph R. Garlich, Jaime Simon
  • Patent number: H1309
    Abstract: A composite is produced by first coating a reinforcing material with an inorganic phosphazene compound and then polymerizing the phosphazene compound so as to confer superior thermal, physical and chemical resistance qualities to the composite.
    Type: Grant
    Filed: July 30, 1990
    Date of Patent: May 3, 1994
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Charles A. Allen, Alan E. Grey, Robert R. McCaffrey, Brenda M. Simpson, Mark L. Stone
  • Patent number: H1310
    Abstract: A process for measuring low levels of cadmium in blood and other biological specimens is provided without interference from high levels of alkali metal contaminants by forming an aqueous solution and without contamination by environmental cadmium absent the proteins from the specimen, selectively removing cadmium from the aqueous solution on an anion exchange resin, thereby removing the alkali metal contaminants, resolubilizing cadmium from the resin to form a second solution and analyzing the second solution for cadmium, the process being carried out in a cadmium-free environment.
    Type: Grant
    Filed: January 29, 1991
    Date of Patent: May 3, 1994
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: David P. Peterson, Edmund A. Huff, Maryka H. Bhattacharyya
  • Patent number: H1312
    Abstract: Disclosed herein is a novel method for preparing a DPTA tripeptide-chelator. In particular, a method for preparing GYK-DTPA is described. The method disclosed herein is an improvement over the known methods of preparation based on the cost and labor savings of the present invention. The present invention utilizes t-butyloxycarbonyl (Boc) protecting groups to facilitate the polypeptide-chelator production.
    Type: Grant
    Filed: May 28, 1992
    Date of Patent: May 3, 1994
    Assignee: Cytogen Corporation
    Inventors: Daniel J. Coughlin, Richard Wood
  • Patent number: H1313
    Abstract: A method of making a product comprising poly(glycidyl azide) by reacting polyepichlorohydrin and alkali and/or alkaline earth metal azides in the presence of certain quaternary amine compounds.
    Type: Grant
    Filed: August 30, 1991
    Date of Patent: May 3, 1994
    Assignee: Minnesota Mining and Manufacturing Company
    Inventors: Kim L. Johnson, Thomas P. Klun